Improving dementia assessment by reducing sample heterogeneity

International Psychogeriatrics

Volumn 19, Issue 3, 2007, Pages 383-389

  Folstein, Marshal ^a,b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c NONE   (United States)

Author keywords

Clinical dementia trials; Hopkins Verbal Learning Test; Mini mental State Examination; Outcome assessment

Indexed keywords

APOLIPOPROTEIN E4;

CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME 21; CHROMOSOME 9; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DEPRESSION; GENE MUTATION; GENETICS; HUMAN; IMAGING; LEARNING; MINI MENTAL STATE EXAMINATION; ONSET AGE; PATHOGENESIS; PATIENT SELECTION; QUESTIONNAIRE; RISK FACTOR;

AGED; ALZHEIMER DISEASE; CLINICAL TRIALS; GERIATRIC ASSESSMENT; HUMANS; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); RISK FACTORS;

EID: 34248143039     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610207005169     Document Type: Conference Paper

References (39)

1. Aguero-Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M. and Winblad, B. (1998). Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. Journal of the American Geriatrics Society, 46, 444-452.
2. Albert, M. S., Moss, M. B., Tanzi, R. and Jones, K. (2001). Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychology Society, 7, 631-639.
3. Alexander, G. E., Prohovnik, I., Sackeim, H. A., Stern, Y. and Mayeux, R. (1995). Cortical perfusion and gray matter weight in frontal lobe dementia. Journal of Neuropsychiatry and Clinical Neuroscience, 7, 188-196.
4. Anthony, J. C., LeResche, L., Niaz, U., von Korff, M. R. and Folstein, M. F. (1982). Limits of the "Mini-Mental State"as a screening test for dementia and delirium among hospital patients. Psychological Medicine, 12, 397-408.
5. Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A. and Bennett, D. A. (2004). Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Archives of Neurology, 61, 661-666.
6. Bassett, S. S., Chase, G. A., Folstein, M. and Regier, D. A. (1998). Disability and psychiatric disorders in an urban community: measurement, prevalence and outcomes.Psychological Medicine, 28, 509-517.
7. Brandt, J., Spencer, M. and Folstein, M. F. (1988). The Telephone Interview for Cognitive Status. Neuropsychiatry, Neuropsychology and Behavioural Neurology, 1, 111-117.
8. Burback, D., Molnar, F. J., St. John, P. and Man-Son-Hing, M. (1999). Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration. Dementia and Geriatric Cognitive Disorders, 10, 534-540.
9. Cercy, S. P. and Bylsma, F. W. (1997). Lewy bodies and progressive dementia: a critical review and meta-analysis. Journal of the International Neuropsychology Society, 3, 179-194.
10. Crum, R. M., Anthony, J. C., Bassett, S. S. and Folstein, M. F. (1993). Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA, 269, 2386-2391.
11. Cummings, J. L. (1997). The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology, 48 (Suppl. 6), S10-16.
12. Devanand, D. P. et al. (1996). Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Archives of General Psychiatry, 53, 175-182.
13. Evans, D. A. et al. (1997). Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. JAMA, 277, 822-824.
14. Flaten, T. P. (2001). Aluminum as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Research Bulletin, 55, 187-196.
15. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental State": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
16. Folstein, M. F. and Whitehouse, P. J. (1983). Cognitive impairment of Alzheimer disease. Journal of Neurobehavior Toxicology and Teratology, 5, 631-634.
17. Frank, R. M. and Byrne, G. J. (2000). The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. International Journal of Geriatric Psychiatry, 15, 317-324.
18. Gatz, M. et al. (2006). Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry, 63, 168-174
19. Han, L., Cole,M., Bellavance, J., McCusker, J. and Primeau, F. (2000). Tracking cognitive decline in Alzheimer's disease using the Mini-mental State Examination: a meta-analysis. International Psychogeriatrics, 12, 231-247.
20. Hardy, J. and Gwinn-Hardy, K. (1998). Genetic classification of primary neurodegenerative disease. Science, 282, 1075-1079.
21. Hatanpaa, K. J. et al. (2004). Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology, 63, 538-542.
22. Hayden, K. M. et al. (2006). Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Disease and Associated Disorders, 20, 93-100.
23. Janofsky, J. S.,McCarthy, R. J. and Folstein, M. F. (1992): The Hopkins competency assessment test: a brief method for evaluating patients' capacity to give informed consent. Hospital and Community Psychiatry, 43, 132-136.
24. Jicha, G. A. et al. (2006). Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Archives of Neurology, 63, 674-681.
25. Karweit, M., Brock, I. P. and Folstein, M. F. (1994). A digital-video medical record system for assessing demented patients. In G. Racagni, N. Brunell and S. Z. Langer (eds.), Recent Advances in the Treatment of Neurodegenerative Disorders and Cognitive Symptoms, Vol. 7 (pp 31-38). Basel: S. Karger Press.
26. Lye, T. C. and Shores, E. A. (2000). Traumatic brain injury as a risk factor for Alzheimer's disease: a review. Neuropsychological Review, 10, 115-129.
27. Mohs, R. C. and Cohen, L. (1988). Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacology Bulletin, 24, 627-628.
28. Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412-2414.
29. Nott, P. N. and Fleminger, J. J. (1975). Presenile dementia: the difficulties of early diagnosis. Acta Psychiatrica Scandinavica, 51, 210-217.
30. Pericak-Vance, M. A. et al. (1997). Complete genomic screen in late-onset familial Alzheimer disease: evidence for a new locus on chromosome 12. JAMA, 278, 1237-1241.
31. Qiu, W. Q. and Folstein, M. F. (2006). Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiology of Aging, 27, 190-198.
32. Rasmusson, D. X., Bylsma, F. W. and Brandt, J. (1995). Stability of performance on the Hopkins Verbal Learning Test. Archives of Clinical Neuropsychology, 10, 21-26.
33. Reisberg, B. et al. (1996). Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. International Psychogeriatrics (Suppl. 3), 301-308, discussion (351-354).
34. Royall,D. R., Mahurin, R. K. andGray, K. F. (1992). Bedside assessment of executive cognitive impairment: the executive interview. Journal of the American Geriatrics Society, 40, 1221-1226.
35. Samuel, W., Terry, R D., DeTeresa, N., Butters, N. and Masliah, E. (1994). Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Archives of Neurology, 51, 772-778.
36. Stern, Y., Mayeux, R., Sano, M., Hauser, W. A. and Bush, T. (1987). Predictors of disease course in patients with probable Alzheimer's disease. Neurology, 37, 1649-1653.
37. Terry, R. D. et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572-580.
38. Tune, L. J. et al. (1991). Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography. Acta Psychiatrica Scandinavica (Suppl.), 366, 61-65.
39. Valenzuela, M. J. and Sachdev, P. (2006). Brain reserve and cognitive decline: a non-parametric systematic review. Psychological Medicine, 36, 1065-1073.